256 related articles for article (PubMed ID: 25089037)
21. Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis,
Chaudhary M; Kumar N; Baldi A; Chandra R; Arockia Babu M; Madan J
J Biomol Struct Dyn; 2020 Jan; 38(1):200-218. PubMed ID: 30784365
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, chemical characterization, biological evaluation, and docking study of new 1,3,4-oxadiazole homonucleoside analogs.
El Mansouri AE; Maatallah M; Ait Benhassou H; Moumen A; Mehdi A; Snoeck R; Andrei G; Zahouily M; Lazrek HB
Nucleosides Nucleotides Nucleic Acids; 2020; 39(8):1088-1107. PubMed ID: 32397827
[TBL] [Abstract][Full Text] [Related]
23. Design and Synthesis of Curcumin-Like Diarylpentanoid Analogues as Potential Anticancer Agents.
Qudjani E; Iman M; Davood A; Ramandi MF; Shafiee A
Recent Pat Anticancer Drug Discov; 2016; 11(3):342-51. PubMed ID: 27094172
[TBL] [Abstract][Full Text] [Related]
24. Discovery of potential HER2 inhibitors from
Balogun TA; Iqbal MN; Saibu OA; Akintubosun MO; Lateef OM; Nneka UC; Abdullateef OT; Omoboyowa DA
J Biomol Struct Dyn; 2022; 40(23):12772-12784. PubMed ID: 34514973
[TBL] [Abstract][Full Text] [Related]
25.
Das SK; Deka SJ; Paul D; Gupta DD; Das TJ; Maravi DK; Tag H; Hui PK
J Biomol Struct Dyn; 2022 Sep; 40(15):6857-6867. PubMed ID: 33625319
[TBL] [Abstract][Full Text] [Related]
26. Fragment-based Discovery of Potential Anticancer Lead: Computational and in vitro Studies.
Balgoname AA; Alomair SM; AlMubirek AK; Khedr MA
Curr Comput Aided Drug Des; 2021; 17(3):421-428. PubMed ID: 32586261
[TBL] [Abstract][Full Text] [Related]
27. Revealing the molecular interactions of aptamers that specifically bind to the extracellular domain of HER2 cancer biomarker protein: An in silico assessment.
Niazi S; Purohit M; Sonawani A; Niazi JH
J Mol Graph Model; 2018 Aug; 83():112-121. PubMed ID: 29902673
[TBL] [Abstract][Full Text] [Related]
28. Hesperetin and Naringenin sensitize HER2 positive cancer cells to death by serving as HER2 Tyrosine Kinase inhibitors.
Chandrika BB; Steephan M; Kumar TRS; Sabu A; Haridas M
Life Sci; 2016 Sep; 160():47-56. PubMed ID: 27449398
[TBL] [Abstract][Full Text] [Related]
29. Combination of In Silico Analysis and In Vitro Assay to Investigate Drug Response to Human Epidermal Growth Factor Receptor 2 Mutations in Lung Cancer.
Yu X; Wang T; Lou Y; Li Y
Mol Inform; 2016 Jan; 35(1):25-35. PubMed ID: 27491651
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, in vitro and in silico evaluation of anti-colorectal cancer activity of curcumin analogues containing 1,3-diphenyl-1H-pyrazole targeting EGFR tyrosine kinase.
Doan NQH; Nguyen NTK; Nguyen NB; Tran TT; Tran QN; Truong TN
Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130414. PubMed ID: 37331408
[TBL] [Abstract][Full Text] [Related]
31. 4-Bromo-4'-chloro pyrazoline analog of curcumin augmented anticancer activity against human cervical cancer, HeLa cells:
Chaudhary M; Kumar N; Baldi A; Chandra R; Babu MA; Madan J
J Biomol Struct Dyn; 2020 Mar; 38(5):1335-1353. PubMed ID: 30957694
[TBL] [Abstract][Full Text] [Related]
32. 3D-QSAR and Molecular Docking Studies on Design Anti-Prostate Cancer Curcumin Analogues.
Meng X; Cui L; Song F; Luan M; Ji J; Si H; Duan Y; Zhai H
Curr Comput Aided Drug Des; 2020; 16(3):245-256. PubMed ID: 30370853
[TBL] [Abstract][Full Text] [Related]
33. 3D-QSAR CoMFA analysis of C5 substituted pyrrolotriazines as HER2 (ErbB2) inhibitors.
Awale M; Mohan CG
J Mol Graph Model; 2008 Apr; 26(7):1169-78. PubMed ID: 18055238
[TBL] [Abstract][Full Text] [Related]
34. Design, Synthesis,
Matada GSP; Abbas N; Dhiwar PS; Basu R; Devasahayam G
Anticancer Agents Med Chem; 2021; 21(4):451-461. PubMed ID: 32698735
[TBL] [Abstract][Full Text] [Related]
35. Discovery of a Potential HER2 Inhibitor from Natural Products for the Treatment of HER2-Positive Breast Cancer.
Li J; Wang H; Li J; Bao J; Wu C
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27376283
[TBL] [Abstract][Full Text] [Related]
36. Lower concentrations of curcumin inhibit Her2-Akt pathway components in human breast cancer cells, and other dietary botanicals potentiate this and lapatinib inhibition.
Saxena AR; Ilic Z; Sripada V; Crawford DR
Nutr Res; 2020 Jun; 78():93-104. PubMed ID: 32563955
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and biological evaluation of novel
Xie X; Tu J; You H; Hu B
Drug Des Devel Ther; 2017; 11():1439-1451. PubMed ID: 28553074
[TBL] [Abstract][Full Text] [Related]
38. Pharmacophore-Based Virtual Screening and In-Silico Explorations of Biomolecules (Curcumin Derivatives) of
Ejaz SA; Aziz M; Fawzy Ramadan M; Fayyaz A; Bilal MS
Molecules; 2023 May; 28(10):. PubMed ID: 37241785
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
[TBL] [Abstract][Full Text] [Related]
40. Atomistic insights into the lung cancer-associated L755P mutation in HER2 resistance to lapatinib: a molecular dynamics study.
Yang B; Zhang H; Wang H
J Mol Model; 2015 Feb; 21(2):24. PubMed ID: 25620423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
